SEC Form EFFECT filed by CTI BioPharma Corp. (DE)

6/30/23 12:15:13 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Notice of Effectiveness

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 29, 2023

Accession Number:

0001193125-23-175042

Submission Type:

POS AM

Date	Price Target	Rating	Analyst
10/17/2022	$13.00	Outperform	SVB Leerink
9/1/2022	$13.00	Buy	Jefferies
7/7/2022	$10.00	Outperform	Cowen
3/2/2022	$4.00 → $5.00	Market Outperform	JMP Securities
3/2/2022	$5.00 → $8.00	Buy	Needham
12/1/2021	$6.00 → $5.00	Buy	Needham
8/9/2021	$7.00	Buy	BTIG Research

Recent Analyst Ratings for
$CTIC